APA (7th ed.) Citation

AG, W., CLY, E., Y, W., NE, S., GA, T., C, L., . . . SA, R. (2025). Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation. Drug safety, 48(2), 107. https://doi.org/10.1007/s40264-024-01488-4

Chicago Style (17th ed.) Citation

AG, Winterstein, et al. "Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation." Drug Safety 48, no. 2 (2025): 107. https://doi.org/10.1007/s40264-024-01488-4.

MLA (9th ed.) Citation

AG, Winterstein, et al. "Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation." Drug Safety, vol. 48, no. 2, 2025, p. 107, https://doi.org/10.1007/s40264-024-01488-4.